- Home
- YOU vs LGND Comparison
YOU vs LGND Comparison
Compare YOU & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- LGND
- Stock Information
- Founded
- YOU 2010
- LGND 1987
- Country
- YOU United States
- LGND United States
- Employees
- YOU N/A
- LGND 68
- Industry
- YOU Computer Software: Prepackaged Software
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- LGND Health Care
- Exchange
- YOU Nasdaq
- LGND Nasdaq
- Market Cap
- YOU 2.3B
- LGND 2.2B
- IPO Year
- YOU 2021
- LGND 1992
- Fundamental
- Price
- YOU $33.73
- LGND $154.48
- Analyst Decision
- YOU Buy
- LGND Strong Buy
- Analyst Count
- YOU 5
- LGND 8
- Target Price
- YOU $34.40
- LGND $144.71
- AVG Volume (30 Days)
- YOU 1.7M
- LGND 139.7K
- Earning Date
- YOU 08-05-2025
- LGND 08-05-2025
- Dividend Yield
- YOU 2.26%
- LGND N/A
- EPS Growth
- YOU 105.20
- LGND N/A
- EPS
- YOU 1.59
- LGND N/A
- Revenue
- YOU $835,529,000.00
- LGND $181,488,000.00
- Revenue This Year
- YOU $14.81
- LGND $18.41
- Revenue Next Year
- YOU $10.46
- LGND $18.87
- P/E Ratio
- YOU $21.41
- LGND N/A
- Revenue Growth
- YOU 19.85
- LGND 53.40
- 52 Week Low
- YOU $21.67
- LGND $81.74
- 52 Week High
- YOU $38.88
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- YOU 73.71
- LGND 69.39
- Support Level
- YOU $31.17
- LGND $137.14
- Resistance Level
- YOU $34.49
- LGND $157.54
- Average True Range (ATR)
- YOU 1.14
- LGND 5.98
- MACD
- YOU 0.29
- LGND 1.27
- Stochastic Oscillator
- YOU 97.05
- LGND 86.51
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.